GLP1R and mood disorder: Interestingly, in the subgroup analysis of drug classes for treating obese patients, GLP-1 RAs were observed to show signals associated with suicide (ROR:1.65, 95% CI:1.28–2.12), with no significant signals detected for anxiety, depression, mood disorders, and self-harm.